Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Clinical Microbiology|November 3, 2020
Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster SeraRanawaka A P M Perera, Ronald Ko, Owen T Y Tsang, et al.
Nature Medicine|January 18, 2023
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive populationJonathan J Lau, Samuel M S Cheng, Kathy Leung, et al.
The Journal of Allergy and Clinical Immunology. Global|April 23, 2026
Four doses of coronavirus disease 2019 vaccination for patients with inborn errors of immunity compared to 3 doses for healthy individualsJeffery C H Chan, Samuel M S Cheng, Daniel Leung, et al.
Nature Communications|April 27, 2023
Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong KongRuopeng Xie, Kimberly M Edwards, Dillon C Adam, et al.
Virology Journal|March 22, 2024
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccinationSamuel M S Cheng, Chris K P Mok, John K C Li, et al.
Nature Communications|May 26, 2022
SARS-CoV-2 accessory proteins reveal distinct serological signatures in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Emerging Infectious Diseases|October 22, 2020
Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020Paul K S Chan, Grace Lui, Asmaa Hachim, et al.
The Lancet. Microbe|August 7, 2023
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trialNancy H L Leung, Samuel M S Cheng, Carolyn A Cohen, et al.
Frontiers in Immunology|March 23, 2023
Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescentsDaniel Leung, Carolyn A Cohen, Xiaofeng Mu, et al.
Clinical Kidney Journal|March 24, 2025
Humoral and cellular immunogenicity of a fourth dose BNT162b2 in children with chronic kidney diseasesJeffery C H Chan, Eugene Yu-Hin Chan, Samuel M S Cheng, et al.
Pageof 6